AI is revolutionizing the way we develop medicines
NewsBytes | March 10, 2026 9:42 PM CST
AI's impact on clinical trials and future investments
AI isn't just about discovering drugs; it's also making clinical trials more efficient.
Tools like GSK's Cogito Forge help design better studies, and digital twins (basically virtual patients) mean fewer real people are needed in control groups.
With pharma companies teaming up with tech firms, investments in AI for drug development could hit $15 billion by 2030, all aiming to bring new therapies to people sooner.
READ NEXT
-
“Wanted To Kill Farooq Abdullah For 20 Years”: Who Is Kamal Singh Jamwal, The Man Behind Shocking Point-Blank Attack?
-
SSLC exams in Udupi district from March 8 to April 2 across 51 centres
-
Farmer ties towel to broken seat in government bus, highlights poor condition
-
Google Maps gets its 'biggest-ever' upgrade: Gemini-powered Ask Maps, 3D navigation and other features announced
-
Aspirants 3 Online Reviews: Netizens Are Raving About The New Season But Are Unhappy With The Ending; Here's Why
